Literature DB >> 2017634

Manifestations of pulmonary cryptococcosis in patients with acquired immunodeficiency syndrome.

M L Cameron1, J A Bartlett, H A Gallis, H A Waskin.   

Abstract

Cryptococcosis is a common opportunistic infection in patients with AIDS. Meningitis is the most frequent manifestation of infection with Cryptococcus neoformans; pneumonia due to this organism, though less frequently recognized, is also a significant entity. A retrospective review was performed of all patients seen at Duke University Medical Center between January 1981 and July 1989 who were infected with both human immunodeficiency virus type 1 and C. neoformans. Of 31 patients with these concomitant infections, 12 had cryptococcal pneumonia (10 definite and two presumptive cases). Eleven of these 12 patients had evidence of extrapulmonary cryptococcal disease as well. Chest radiography showed interstitial infiltrates in 11 instances. For ten of the 12 patients, pulmonary cultures were positive for C. neoformans. Bronchoalveolar lavage fluid from all five patients who underwent bronchoscopy yielded the organism. Acute-phase mortality from cryptococcosis was 42% among patients with pneumonia. Cryptococcal pneumonia in patients with AIDS is probably more common than has previously been recognized and typically presents as interstitial disease that may mimic other opportunistic infections.

Entities:  

Mesh:

Year:  1991        PMID: 2017634     DOI: 10.1093/clinids/13.1.64

Source DB:  PubMed          Journal:  Rev Infect Dis        ISSN: 0162-0886


  20 in total

1.  Pulmonary cryptococcosis.

Authors:  G B Huffnagle; M F Lipscomb
Journal:  Am J Pathol       Date:  1992-12       Impact factor: 4.307

2.  Chest radiography for predicting the cause of febrile illness among inpatients in Moshi, Tanzania.

Authors:  S P Fiorillo; H C Diefenthal; P C Goodman; H O Ramadhani; B N Njau; A B Morrissey; V P Maro; W Saganda; G D Kinabo; M S Mwako; J A Bartlett; J A Crump
Journal:  Clin Radiol       Date:  2013-06-26       Impact factor: 2.350

3.  Screening for cryptococcal antigenemia in anti-retroviral naïve AIDS patients in benin city, Nigeria.

Authors:  Favour Osazuwa; John Osilume Dirisu; Patrick Evbaguehita Okuonghae; Ose Ugbebor
Journal:  Oman Med J       Date:  2012-05

4.  A vitamin-free minimal synthetic medium for Cryptococcus neoformans.

Authors:  V Vidotto; S Aoki; G Campanini
Journal:  Mycopathologia       Date:  1996       Impact factor: 2.574

Review 5.  Bronchoscopic diagnosis of pneumonia.

Authors:  V S Baselski; R G Wunderink
Journal:  Clin Microbiol Rev       Date:  1994-10       Impact factor: 26.132

6.  Cavitating pulmonary cryptococcosis developing in an HIV antibody patient despite prior treatment with fluconazole.

Authors:  R J Coker; D Bell; B S Peters; S M Murphy
Journal:  Genitourin Med       Date:  1992-02

Review 7.  Other HIV-associated pneumonias.

Authors:  Jakrapun Pupaibool; Andrew H Limper
Journal:  Clin Chest Med       Date:  2013-04-08       Impact factor: 2.878

8.  Evaluation of a monoclonal antibody-based latex agglutination test for diagnosis of cryptococcosis: comparison with two tests using polyclonal antibodies.

Authors:  A Temstet; P Roux; J L Poirot; O Ronin; F Dromer
Journal:  J Clin Microbiol       Date:  1992-10       Impact factor: 5.948

9.  Pulmonary cryptococcosis in solid organ transplant recipients: clinical relevance of serum cryptococcal antigen.

Authors:  Nina Singh; Barbara D Alexander; Olivier Lortholary; Françoise Dromer; Krishan L Gupta; George T John; Ramon del Busto; Goran B Klintmalm; Jyoti Somani; G Marshall Lyon; Kenneth Pursell; Valentina Stosor; Patricia Muñoz; Ajit P Limaye; Andre C Kalil; Timothy L Pruett; Julia Garcia-Diaz; Atul Humar; Sally Houston; Andrew A House; Dannah Wray; Susan Orloff; Lorraine A Dowdy; Robert A Fisher; Joseph Heitman; Marilyn M Wagener; Shahid Husain
Journal:  Clin Infect Dis       Date:  2008-01-15       Impact factor: 9.079

10.  Activity of MS-8209, a nonester amphotericin B derivative, in treatment of experimental systemic mycoses.

Authors:  L Saint-Julien; V Joly; M Seman; C Carbon; P Yeni
Journal:  Antimicrob Agents Chemother       Date:  1992-12       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.